Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Binder-Nissim A"'
Autor:
Ming-Ru Wu, Lior Nissim, Doron Stupp, Erez Pery, Adina Binder-Nissim, Karen Weisinger, Casper Enghuus, Sebastian R. Palacios, Melissa Humphrey, Zhizhuo Zhang, Eva Maria Novoa, Manolis Kellis, Ron Weiss, Samuel D. Rabkin, Yuval Tabach, Timothy K. Lu
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
Synthetic promoters can be superior to native ones but the design is challenging without knowledge of gene regulation. Here the authors develop a pipeline that allows for screening a synthetic promoter library to identify high performance promoters i
Externí odkaz:
https://doaj.org/article/4058b7f205214aa99e7ffdf21a5903d9
Autor:
Nissim, Lior, Wu, Ming-Ru, Pery, Erez, Binder-Nissim, Adina, Suzuki, Hiroshi I., Stupp, Doron, Wehrspaun, Claudia, Tabach, Yuval, Sharp, Phillip A., Lu, Timothy K.
Publikováno v:
In Cell 16 November 2017 171(5):1138-1150
Autor:
Heather E. Fleming, Sangeeta N. Bhatia, Timothy K. Lu, Lior Nissim, Adina Binder-Nissim, Ava P. Soleimany, Jiang He
Publikováno v:
ACS Synthetic Biology. 10:2231-2242
The integration of nanotechnology and synthetic biology could lay the framework for new classes of engineered biosensors that produce amplified readouts of disease states. As a proof-of-concept demonstration of this vision, here we present an enginee
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Melissa R. Humphrey, Samuel D. Rabkin, Karen Weisinger, Erez Pery, Ming-Ru Wu, Manolis Kellis, Timothy K. Lu, Eva Maria Novoa, Ron Weiss, Zhizhuo Zhang, Doron Stupp, Casper Enghuus, Lior Nissim, Yuval Tabach, Sebastian Palacios, Adina Binder-Nissim
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
Nature Communications
Nature Communications
Cell state-specific promoters constitute essential tools for basic research and biotechnology because they activate gene expression only under certain biological conditions. Synthetic Promoters with Enhanced Cell-State Specificity (SPECS) can be supe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf09087bc9126d2f959093302f6b08c
http://hdl.handle.net/10230/42319
http://hdl.handle.net/10230/42319
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Phillip A. Sharp, Claudia Wehrspaun, Hiroshi I. Suzuki, Adina Binder-Nissim, Doron Stupp, Ming-Ru Wu, Lior Nissim, Yuval Tabach, Timothy K. Lu, Erez Pery
Publikováno v:
PMC
Despite its success in several clinical trials, cancer immunotherapy remains limited by the rarity of targetable tumor-specific antigens, tumor-mediated immune suppression, and toxicity triggered by systemic delivery of potent immunomodulators. Here,